HCPCS Code Q5116

Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg
Code effective Oct 01, 2019

HCPCS Section
Miscellaneous Services (Temporary Codes)

Q5116 is a valid 2026 HCPCS code meaning Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg or (Inj., trazimera, 10 mg) for short. HCPCS Q5116 has been effective since 10/01/2019 and applies to Medical care.

HCPCS Code Details - Q5116

HCPCS Level II Code
Section Q - Miscellaneous Services (Temporary Codes)
HCPCS Code Q5116
Description

Long description:
Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg

Short description:
Inj., trazimera, 10 mg

HCPCS Pricing indicator 51 - Drugs
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code C - Carrier judgment
BETOS2 code O1E - Other drugs
HCPCS Action code N - No maintenance for this code
Type of service 1 - Medical care
Effective date Effective Oct 01, 2019
Date added Added Oct 01, 2019

See also

  • HCPCS Q5115 · Injection, rituximab-abbs, biosimilar, (truxima), 10 mg

  • HCPCS Q5117 · Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/4/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.